Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Biofrontier Partners

investment firm

About

Founded in 2001, Biofrontier Partners is a California-based private equity company that also provides research and analysis solutions.

Details

Founded date
Jan 1, 1999
Operating Status
Active
Investor Type
Venture Capital

Investments

Number of Investments
Number of Lead Investments
10
0
Biofrontier Partners has made 10 investments. Their most recent investment was on Jan 6, 2006, when Perlegen Sciences raised $50M.
Date Company Name
Round Money Raised Industry Lead Investor
Series D $50M Biotechnology
Jul 16, 2005 BioTrove
Series B $5M Biotechnology
Feb 28, 2005 Perlegen Sciences
Series D $74M Biotechnology
Jan 29, 2004 BioTrove
Series B $10.90M Biotechnology
Mar 17, 2003 CellZome
Series C €30M Biotechnology

Exits

Biofrontier Partners has had 5 exits. Biofrontier Partners most notable exits include CellZome ,   BioTrove

Date Company Name Exit Type Industry
May 15, 2012 CellZome M&A Biotechnology Detail
Nov 10, 2009 BioTrove M&A Biotechnology Detail
Mar 19, 2008 CardioNet IPO Biotechnology Detail
May 12, 2005 Salmedix M&A Biotechnology Detail
Oct 4, 2002 AnGes IPO Biopharma Detail